Significant IgG subclass heterogeneity in HLA-specific antibodies: Implications for pathogenicity, prognosis, and the rejection response

Human Immunology

Volumn 74, Issue 5, 2013, Pages 666-672

  Lowe, D ^a,b   Higgins, R ^c   Zehnder, D ^b,c   Briggs, D C ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

AMR; DSA; HLA; MFI; PE; TPA

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4;

ARTICLE; CONTROLLED STUDY; GRAFT FAILURE; GRAFT REJECTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PATHOGENICITY; PRIORITY JOURNAL; PROGNOSIS;

ANTIBODY SPECIFICITY; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; PREGNANCY; PROGNOSIS; TRANSPLANTATION IMMUNOLOGY;

EID: 84876336190     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.01.008     Document Type: Article

References (15)

1. Cook D.J., et al. Flow cytometry crossmatching for kidney transplantation. Clin Transpl 1988, 375-380.
2. Talbot D. Flow cytometric crossmatching in human organ transplantation. Transpl Immunol 1994, 2(2):138-139.
3. Gupta A., et al. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?. Transplantation 2008, 85(8):1200-1204.
4. Claas F.H. Clinical relevance of circulating donor-specific HLA antibodies. Curr Opin Organ Transplant 2010, 15(4):462-466.
5. Koka P., et al. The role of IgA anti-HLA class I antibodies in kidney transplant survival. Transplantation 1993, 56(1):207-211.
6. Chapman J.R., et al. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Relationship to renal transplant outcome. Transplantation 1986, 42(6):608-613.
7. Lobashevsky A., et al. Subtypes of immunoglobulin (Ig)-G antibodies against donor class II HLA and cross-match results in three kidney transplant candidates. Transpl Immunol 2010, 23(1-2):81-85.
8. Honger G., et al. Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection. Transplantation 2011, 92(1):41-47.
9. Higgins R., et al. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody. Transplantation 2007, 84(7):876-884.
10. El-Awar N., et al. New HLA class I epitopes defined by murine monoclonal antibodies. Hum Immunol 2010, 71(5):456-461.
11. Kushihata F., et al. Human leukocyte antigen antibodies and human complement activation: role of IgG subclass, specificity, and cytotoxic potential. Transplantation 2004, 78(7):995-1001.
12. Thomas N.C., et al. A quantitative assay for subclassing IgG alloantibodies implicated in hemolytic disease of the newborn. Vox Sang 1995, 69(2):120-125.
13. Pollock J.M., Bowman J.M. Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newborn. Vox Sang 1990, 59(3):176-179.
14. Griffiths E.J., et al. Skewing of pretransplant anti-HLA class I antibodies of immunoglobulin G isotype solely toward immunoglobulin G1 subclass is associated with poorer renal allograft survival. Transplantation 2004, 77(11):1771-1773.
15. Norman D.J., Barry J.M., Wetzsteon P.J. Successful cadaver kidney transplantation in patients highly sensitized by blood transfusions. Unimportance of the most reactive serum in the pretransplant crossmatch. Transplantation 1985, 39(3):253-255.